Viewing Study NCT06419686



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06419686
Status: RECRUITING
Last Update Posted: 2024-05-17
First Post: 2024-05-13

Brief Title: The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals
Sponsor: University Hospital Gentofte Copenhagen
Organization: University Hospital Gentofte Copenhagen

Study Overview

Official Title: The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GIPALANIN
Brief Summary: The study is a randomised double-blinded placebo-controlled crossover study enrolling 10 healthy male participants Each participant will undergo four separate study days in randomised order Each study day encompasses a continous 90-minute iv infusion with either placebo glucose-dependent insulinotropic polypeptide GIP alanine or GIP alanine

The primary objective of the study is to find out whether intravenous administration of the naturally occuring gut hormone GIP and the amino acid alanine separately and combined results in additive or synergistic glucagonotropic effects during euglycaemic conditions in healthy participants Secondary objectives are to disclose the effect of the abovementioned interventions on insulin secretion and circulating levels of total and individual amino acids
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None